Royalty Pharma plc (RPRX) current stock price is $28.76. During the last trading session, the stock soared, reaching $29.24 after opening at $28.78. The stock’s lowest point was $28.691 before it closed at $28.77.
The stock market performance of Royalty Pharma plc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $44.47 on 12/01/22, while the lowest price during the same time frame was $28.45, recorded on 09/07/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of RPRX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Royalty Pharma plc’s current trading price is -35.33% away from its 52-week high, while its distance from the 52-week low is 1.07%. The stock’s price range during this period has fluctuated between $28.45 and $44.47. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 2.61 million for the day, which was evidently higher than the average daily volume of 2.27 million over the last three months.
Financial Performance and Market Capitalization
Royalty Pharma plc (RPRX) has experienced a quarterly decline of -10.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.11B and boasts a workforce of 75 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 31.67, with a change in price of -7.34. Similarly, Royalty Pharma plc recorded 2,260,041 in trading volume during the last 100 days, posting a change of -20.33%.
RPRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RPRX stands at 1.13. Similarly, the long-term debt-to-equity ratio is also 0.98.
RPRX Stock Stochastic Average
The raw stochastic average for Royalty Pharma plc over the last 50 days is presently at 9.85%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 12.63%. Further, the company’s Stochastic %K and %D values for the last 20 days were 18.15% and 22.48%, respectively.
RPRX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -27.23%. However, over the last six months, the performance has been stronger by -16.64%. The price of RPRX decreased -3.49% over the last 30 days. And in the last five days, it has fallen by -0.35%.
